FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200353823> ?p ?o ?g. }

• W4200353823 endingPage "610" @default.
• W4200353823 startingPage "606" @default.
• W4200353823 abstract "Quantitation of anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) neutralizing antibodies (Nabs) is a key parameter in determining the effective dose for treatment with COVID-19 convalescent plasma (CCP). Interpretation of results from clinical trials conducted worldwide requires comparison of Nabs titres obtained from different methods. As virus neutralization tests (VNTs) are not standardized scalable or commercially available, strategies based on intensity of ELISA (Enzyme Linked Immunosorbent Assay) or chemiluminescent binding serological tests were implemented to allow comparisons and establish criteria for determining 'high-titres' of anti-SARS-CoV-2 antibodies (Abs). To this end, the FDA (Food and Drug Administration) has proposed criteria to define high-titre plasmas using different serological assays, including the one used in France for the CCP SARS-CoV-2 Abs screening (Euroimmun anti-S1 IgG). A retrospective study revealed that when using the FDA criteria (ELISA signal-to-cut-off [S/C ratio] ≥3.5), 91% of CCP had Nabs titres ≥40 as assessed with an in-house VNT. French strategy to ensure sufficient stocks of CCP of increasing titre has evolved over time. Recently, we improved our strategy by collecting only plasma from vaccinated convalescent donors as we confirmed that the mean IgG antibody level (ELISA S/C ratio) was significantly higher in plasma from vaccinated convalescent donors compared to donations from unvaccinated convalescent donors: 9.31 (CI 95%: 8.46-10.16) versus 3.22 (CI 95%: 3.05-3.39) (p < 0.001)." @default.
• W4200353823 created "2021-12-31" @default.
• W4200353823 creator A5004908385 @default.
• W4200353823 creator A5005198529 @default.
• W4200353823 creator A5029675225 @default.
• W4200353823 creator A5053644134 @default.
• W4200353823 creator A5054639738 @default.
• W4200353823 creator A5058777157 @default.
• W4200353823 creator A5063671529 @default.
• W4200353823 creator A5067395185 @default.
• W4200353823 creator A5078450368 @default.
• W4200353823 creator A5079110429 @default.
• W4200353823 creator A5083271501 @default.
• W4200353823 date "2021-12-12" @default.
• W4200353823 modified "2023-10-18" @default.
• W4200353823 title "COVID‐19 convalescent plasma: Evolving strategies for serological screening in France" @default.
• W4200353823 cites W3013742505 @default.
• W4200353823 cites W3014735311 @default.
• W4200353823 cites W3016900702 @default.
• W4200353823 cites W3032394272 @default.
• W4200353823 cites W3043138331 @default.
• W4200353823 cites W3048117004 @default.
• W4200353823 cites W3048907206 @default.
• W4200353823 cites W3083350600 @default.
• W4200353823 cites W3084037335 @default.
• W4200353823 cites W3118278606 @default.
• W4200353823 cites W3119294059 @default.
• W4200353823 cites W3120705490 @default.
• W4200353823 cites W3121016799 @default.
• W4200353823 cites W3136570200 @default.
• W4200353823 cites W3178032381 @default.
• W4200353823 cites W3181682276 @default.
• W4200353823 doi "https://doi.org/10.1111/vox.13228" @default.
• W4200353823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34897745" @default.
• W4200353823 hasPublicationYear "2021" @default.
• W4200353823 type Work @default.
• W4200353823 citedByCount "3" @default.
• W4200353823 countsByYear W42003538232022 @default.
• W4200353823 countsByYear W42003538232023 @default.
• W4200353823 crossrefType "journal-article" @default.
• W4200353823 hasAuthorship W4200353823A5004908385 @default.
• W4200353823 hasAuthorship W4200353823A5005198529 @default.
• W4200353823 hasAuthorship W4200353823A5029675225 @default.
• W4200353823 hasAuthorship W4200353823A5053644134 @default.
• W4200353823 hasAuthorship W4200353823A5054639738 @default.
• W4200353823 hasAuthorship W4200353823A5058777157 @default.
• W4200353823 hasAuthorship W4200353823A5063671529 @default.
• W4200353823 hasAuthorship W4200353823A5067395185 @default.
• W4200353823 hasAuthorship W4200353823A5078450368 @default.
• W4200353823 hasAuthorship W4200353823A5079110429 @default.
• W4200353823 hasAuthorship W4200353823A5083271501 @default.
• W4200353823 hasConcept C126322002 @default.
• W4200353823 hasConcept C159047783 @default.
• W4200353823 hasConcept C159654299 @default.
• W4200353823 hasConcept C203014093 @default.
• W4200353823 hasConcept C2779134260 @default.
• W4200353823 hasConcept C3007834351 @default.
• W4200353823 hasConcept C3008058167 @default.
• W4200353823 hasConcept C3018027319 @default.
• W4200353823 hasConcept C3018890749 @default.
• W4200353823 hasConcept C32611913 @default.
• W4200353823 hasConcept C45189115 @default.
• W4200353823 hasConcept C524204448 @default.
• W4200353823 hasConcept C71924100 @default.
• W4200353823 hasConcept C98274493 @default.
• W4200353823 hasConceptScore W4200353823C126322002 @default.
• W4200353823 hasConceptScore W4200353823C159047783 @default.
• W4200353823 hasConceptScore W4200353823C159654299 @default.
• W4200353823 hasConceptScore W4200353823C203014093 @default.
• W4200353823 hasConceptScore W4200353823C2779134260 @default.
• W4200353823 hasConceptScore W4200353823C3007834351 @default.
• W4200353823 hasConceptScore W4200353823C3008058167 @default.
• W4200353823 hasConceptScore W4200353823C3018027319 @default.
• W4200353823 hasConceptScore W4200353823C3018890749 @default.
• W4200353823 hasConceptScore W4200353823C32611913 @default.
• W4200353823 hasConceptScore W4200353823C45189115 @default.
• W4200353823 hasConceptScore W4200353823C524204448 @default.
• W4200353823 hasConceptScore W4200353823C71924100 @default.
• W4200353823 hasConceptScore W4200353823C98274493 @default.
• W4200353823 hasIssue "4" @default.
• W4200353823 hasLocation W42003538231 @default.
• W4200353823 hasLocation W42003538232 @default.
• W4200353823 hasLocation W42003538233 @default.
• W4200353823 hasLocation W42003538234 @default.
• W4200353823 hasOpenAccess W4200353823 @default.
• W4200353823 hasPrimaryLocation W42003538231 @default.
• W4200353823 hasRelatedWork W1984647379 @default.
• W4200353823 hasRelatedWork W3021898730 @default.
• W4200353823 hasRelatedWork W3082210356 @default.
• W4200353823 hasRelatedWork W3134744114 @default.
• W4200353823 hasRelatedWork W4210401150 @default.
• W4200353823 hasRelatedWork W4210525786 @default.
• W4200353823 hasRelatedWork W4214661089 @default.
• W4200353823 hasRelatedWork W4321179355 @default.
• W4200353823 hasRelatedWork W4385264226 @default.
• W4200353823 hasRelatedWork W3202143347 @default.
• W4200353823 hasVolume "117" @default.
• W4200353823 isParatext "false" @default.

• next